Mage Group is a British, clinical-stage BIOTECHNOLOGY HOLDING COMPANY, ‘’A Full Biotech Ecosystem’’ dealing with the problems and dysfunctions related to External and Internal aging. Mage Group focuses on the quest to increase human lifespan as well as healthspan by developing Off-the-shelf, Bio-intelligent treatment modalities including autologous stem cells, autologous, xenogeneic and synthetic exosome products, targeting indications across aging, wound healing, soft tissue defect, reconstructive indications, degenerative diseases.